DnB Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Buy |
29,362
+6,984
| +31% | +$65.4K | ﹤0.01% | 678 |
|
|
2025
Q1 | $275K | Sell |
22,378
-565
| -2% | -$6.94K | ﹤0.01% | 694 |
|
|
2024
Q4 | $303K | Buy |
22,943
+5,581
| +32% | +$73.8K | ﹤0.01% | 688 |
|
|
2024
Q3 | $334K | Buy |
17,362
+4,190
| +32% | +$80.7K | ﹤0.01% | 676 |
|
|
2024
Q2 | $270K | Buy |
13,172
+3,804
| +41% | +$78.1K | ﹤0.01% | 679 |
|
|
2024
Q1 | $223K | Buy |
+9,368
| New | +$223K | ﹤0.01% | 693 |
|